Overview

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, placebo-controlled, flexible-dose, parallel-group study designed to evaluate the efficacy and safety of lurasidone (in combination with lithium or divalproex) for the maintenance treatment of bipolar I disorder in subjects with or without rapid cycling and /or psychotic features.
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
Lurasidone Hydrochloride